Erratum: An Economic Evaluation of Aripiprazole vs Olanzapine Adapted to the Italian Setting Using Outcomes of Metabolic Syndrome and Risk for Diabetes in Patients With Schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976
Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s5342
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2009
Authors
Publisher
Informa UK Limited